Diabetic Medicine

Thoughts of a departing Editor
pp. 1261-1262(2)
Author: S. Heller

Persistent poor glycaemic control in adult Type 1 diabetes. A closer look at the problem
pp. 1263-1268(6)
Authors: J. H. DeVries; F. J. Snoek; R. J. Heine

Intravenous drug abuse and Type 1 diabetes: financial and healthcare implications
pp. 1269-1273(5)
Authors: S. A. Saunders; J. Democratis; J. Martin; I. A. Macfarlane

Effects of a structured health education programme by a diabetic education nurse on cardiovascular risk factors in Chinese Type 2 diabetic patients: a 1-year prospective randomized study
pp. 1274-1279(6)
Authors: G. T. C. Ko; J. K. Y. Li; E. C. Y. Kan; M. K. W. Lo

Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone
pp. 1280-1287(8)
Authors: K. Hällsten; K. A. Virtanen; F. Lönnqvist; T. Janatuinen; M. Turiceanu; T. Rönnemaa; J. Viikari; T. Lehtimäki; J. Knuuti; P. Nuutila

Feasibility of a quality assurance programme of bedside blood glucose testing in a hospital setting: 7 years’ experience
pp. 1288-1291(4)
Authors: F. Nobels; F. Beckers; E. Bailleul; P. De Schrijver; L. Sierens; P. Van Crombrugge

Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy
pp. 1292-1297(6)
Authors: A. Tashimo; Y. Mitamura; S. Nagai; Y. Nakamura; K. Ohtsuka; Y. Mizue; J. Nishihira

Effect of insulin treatment on the body composition of Type 2 diabetic patients
pp. 1298-1303(6)
Authors: A. Sallé; G. Guilloteau; M. Ryan; B Bouhanick; P. Ritz

Early parasympathetic neuropathy associated with elevated fasting plasma C-peptide concentrations and late parasympathetic neuropathy with hyperglycaemia and other microvascular complications
pp. 1304-1309(6)
Authors: A. Gottsäter; M. Kangro; G. Sundkvist

Studies of the Ala/Val98 polymorphism of the hepatocyte nuclear factor-1 gene and the relationship to -cell function during an OGTT in glucose-tolerant women with and without previous gestational diabetes mellitus
pp. 1310-1315(6)
Authors: J. Lauenborg; P. Damm; J. Ek; C. Glümer; T. Jørgensen; K. Borch-Johnsen; H. Vestergaard; P. Hornnes; O. Pedersen; T. Hansen

Exploring the idiotypes of insulin antibodies as markers for remission in Type 1 diabetes
pp. 1316-1324(9)
Authors: D. Devendra; T. S. Galloway; S. J. Horton; T. J. Wilkin

Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes
pp. 1325-1333(9)
Authors: K. Sivenius; L. Niskanen; R. Voutilainen-Kaunisto; M. Laakso; M. Uusitupa

Erythromelia, or Mitchell's syndrome – new names for unexplained signs of inflammation in distal symmetrical neuropathy in diabetes
pp. 1334-1338(5)
Authors: W. J. Jeffcoate; I. Idris; F. L. Game

Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects
pp. 1339-1345(7)
Authors: G. Valsamakis; R. Chetty; A. Anwar; A. K. Banerjee; A. Barnett; S. Kumar

Oxidative stress and glucose levels in a population-based sample
pp. 1346-1352(7)
Authors: V. Menon; M. Ram; J. Dorn; D. Armstrong; P. Muti; J. L. Freudenheim; R. Browne; H. Schunemann; M. Trevisan

Prevalence of Diabetic Eye disease in Tayside, Scotland (P-DETS) Study: methodology
pp. 1353-1356(4)
Authors: J. D. Ellis; G. Leese; R. McAlpine; A. Cole; C. J. MacEwen; P. S. Baines; I. Crombie; A. D. Morris

Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS)
pp. 1357-1365(9)
Authors: J. P. O'Hare; N. T. Raymond; S. Mughal; L. Dodd; W. Hanif; Y. Ahmad; K. Mishra; A. Jones; S. Kumar; A. Szczepura; E. W. Hillhouse; A. H. Barnett

Reversible cognitive deterioration after a single episode of severe hypoglycaemia: a case report
pp. 1366-1367(2)
Authors: T. Kubiak; B. Kuhr; D. Inselmann; N. Hermanns; B. Kulzer; T. Haak

Changing aspirin use in patients with Type 2 diabetes in the UKPDS
pp. 1368-1371(4)
Authors: C. A. Cull; H. A. W. Neil; R. R. Holman

The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Schuffman and Carr
pp. 1372-1372(1)
Authors: A. J. Palmer; S. Roze; W. J. Valentine; G. Spinas

Reply
pp. 1372-1373(2)
Authors: P. A. Scuffham; L. Carr

Re: post-prandial hypoglycaemia due to insulin lispro or insulin aspart
pp. 1373-1373(1)
Author: A. C. Felix Burden

Diabetic Medicine diary
pp. 1374-1374(1)

List of reviewers 2004
pp. 1375-1378(4)

Indexes
pp. 1379-1400(22)